Selecting patients for gastrectomy in metastatic esophago-gastric cancer: clinics and pathology are not enough

被引:13
|
作者
Fornaro, Lorenzo [1 ]
Fanotto, Valentina [2 ]
Musettini, Gianna [1 ]
Uccello, Mario [3 ]
Rimassa, Lorenza [4 ]
Vivaldi, Caterina [1 ]
Fontanella, Caterina [2 ]
Leone, Francesco [5 ]
Giampieri, Riccardo [6 ]
Rosati, Gerardo [7 ]
Lencioni, Monica [1 ]
Santini, Daniele [8 ]
Di Donato, Samantha [9 ]
Tomasello, Gianluca [10 ]
Brunetti, Oronzo [11 ]
Pietrantonio, Filippo [12 ]
Bergamo, Francesca [13 ]
Scartozzi, Mario [14 ]
Avallone, Antonio [15 ]
Lutrino, Stefania Eufemia [16 ]
Melisi, Davide [17 ]
Antonuzzo, Lorenzo [18 ]
Pellegrino, Antonio [19 ]
Gerratana, Lorenzo [2 ]
Cordio, Stefano [3 ]
Vasile, Enrico [1 ]
Aprile, Giuseppe [2 ,20 ]
机构
[1] Azienda Osped Univ Pisana, Unit Med Oncol 2, I-56126 Pisa, Italy
[2] Univ & Gen Hosp, Dept Oncol, I-33100 Udine, Italy
[3] Garibaldi Nesima Hosp, Dept Oncol, I-95122 Catania, Italy
[4] Humanitas Clin & Res Ctr, Humanitas Canc Ctr, Med Oncol & Hematol Unit, I-20089 Rozzano, MI, Italy
[5] IRCCS, Inst Canc Res & Treatment, I-10060 Candiolo, TO, Italy
[6] Osped Riuniti, Unit Med Oncol, I-60126 Ancona, Italy
[7] San Carlo Hosp, Unit Med Oncol, I-85100 Potenza, Italy
[8] Campus Biomed Univ, Med Oncol, I-00128 Rome, Italy
[9] Gen Hosp, Dept Med Oncol, I-59100 Prato, Italy
[10] Ist Ospitalieri Cremona, Med Oncol Div, I-26100 Cremona, Italy
[11] Natl Canc Inst IRCCS Giovanni Paolo II, Unit Med Oncol, I-70124 Bari, Italy
[12] Natl Canc Inst IRCCS, Med Oncol, I-20133 Milan, Italy
[13] IOV IRCCS, Med Oncol, I-35128 Padua, Italy
[14] Univ Cagliari, Univ Hosp, Unit Med Oncol, I-09124 Cagliari, Italy
[15] IRCCS Fdn G Pascale, Natl Canc Inst, Gastrointestinal Oncol, I-80131 Naples, Italy
[16] Perrino Hosp, Unit Med Oncol, I-72100 Brindisi, Italy
[17] Univ Verona, Unit Med Oncol, I-37126 Verona, Italy
[18] Careggi Univ Hosp, Unit Med Oncol, I-50134 Florence, Italy
[19] Vito Fazzi Hosp, Unit Oncol, I-73100 Lecce, Italy
[20] ULSS 8 Berica East Dist, San Bortolo Gen Hosp, Dept Oncol, I-36100 Vicenza, Italy
关键词
chemotherapy; metastatic gastric cancer; palliative gastrectomy; GASTRIC-CANCER; PALLIATIVE RESECTION; DOUBLE-BLIND; CHEMOTHERAPY; SURGERY; ADENOCARCINOMA; PHASE-3; GUIDELINES;
D O I
10.2217/fon-2017-0246
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To evaluate the impact on overall survival (OS) of gastrectomy in asymptomatic metastaticesophago-gastriccancer.Patients&methods: Five hundred and thirteen patients were included. The role of surgery and other clinico-pathological factors was evaluated by univariate and Cox regression analyses. OS was the primary end point. Results: Multivariate analysis confirmed that gastrectomy was a predictor of longer OS (p < 0.001), as well as preserved performance status and benefit from first-line chemotherapy. None of the investigated clinico-pathological variables identified preferable candidates for surgery (all p > 0.05). Conclusion: Palliative gastrectomy might play a role in asymptomatic metastatic esophago-gastric cancer patients with good performance status who received benefit from first-line chemotherapy. Future prospective trials integrating tumor biology among inclusion criteria may help defining the optimal candidates.
引用
收藏
页码:2265 / 2275
页数:11
相关论文
共 50 条
  • [21] Esophago-Gastric Pathology in Morbid Obese: Preoperative Diagnosis and Influence in Technique Selection
    Sanchez-Santos, R.
    Tome Espineira, C.
    Estevez Fernandez, S.
    Gonzalez Fernandez, S.
    Vazquez Astray, E.
    Turnes, J.
    Ulla, J. L.
    Brox, A.
    Marino, E.
    Pinon Cimadevila, M.
    OBESITY SURGERY, 2011, 21 (08) : 962 - 962
  • [22] Management of Oligometastatic Disease in Esophago-Gastric Cancer - What is the Evidence ?
    Hingorani, Mohan
    Stubley, Hannah
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 (7-8) : 312 - 319
  • [23] In Reply: Stent Placement in Treatment of Esophageal or Esophago-Gastric Cancer
    Langer, Felix B.
    Zacherl, Johannes
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (01) : 287 - 288
  • [24] In Reply: Stent Placement in Treatment of Esophageal or Esophago-Gastric Cancer
    Felix B. Langer
    Johannes Zacherl
    Annals of Surgical Oncology, 2011, 18 : 287 - 288
  • [25] The identification of predictive factors for perioperative chemotherapy in esophago-gastric cancer
    Lordick, F.
    Roecken, C.
    ANNALS OF ONCOLOGY, 2013, 24 (05) : 1135 - 1138
  • [26] Anti-angiogenic therapies for advanced esophago-gastric cancer
    Fontana, Elisa
    Sclafani, Francesco
    Cunningham, David
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2014, 35 (04) : 253 - 262
  • [27] Emergency treatment of esophago-gastric lesion in caustic ingestion patients
    F Conforto
    M Gerecitano
    I Tanga
    A Mereu
    A Sansonetti
    C Huscher
    Critical Care, 8 (Suppl 1):
  • [28] Is centralization needed for esophago-gastric cancer patients with low operative risk? a nationwide study
    Gronnier, C.
    Pasquer, A.
    Renaud, F.
    Hec, F.
    Gandon, A.
    Vanderbeken, M.
    Drubay, V.
    Caranhac, G.
    Piessen, G.
    Mariette, C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [29] Evaluating the Availability of Services for Cancer Patients Following Surgical Resection of Esophago-Gastric Tumours
    Al-Housni, Ragad
    Gossage, James
    BRITISH JOURNAL OF SURGERY, 2021, 108
  • [30] ESOPHAGO-GASTRIC INVAGINATION IN PATIENTS WITH SLIDING HIATUS-HERNIA
    GHAHREMANI, GG
    COLLINS, PA
    GASTROINTESTINAL RADIOLOGY, 1976, 1 (03): : 253 - 261